ETS2 and HIV infectious disease: Competition between the viral LTR and endogenous cellular promoter targets for Ets-2 could provide a unifying mechanism behind the autoimmune phenomena observed during HIV infection, present in 1–60% of all infected patients (43–48), as well as the role of natural infections in enhancing viral replication (49–52).